Circular RNA CCDC66 promotes gastric cancer progression by regulating c-Myc and TGF-β signaling pathways

Guifang Xu, Yanke Chen, Min Fu, Xueyan Zang, Mingming Cang, Yanlong Niu, Weiya Zhang, Yu Zhang, Zheying Mao, Meng Shao, Hui Qian, Wenrong Xu, Hui Cai, Pengcheng Jiang, Xu ZhangJournal of Cancer 2020 · DOI

Introduction

Gastric cancer (GC) remains a significant global health burden, characterized by high mortality rates and often poor prognosis due to late-stage diagnosis. While traditional research has focused on protein-coding genes, the emergence of non-coding RNAs, particularly circular RNAs (circRNAs), has opened new avenues for understanding cancer biology. circRNAs are unique due to their covalently closed loop structure, which grants them exceptional stability against cellular degradation. This study investigates the role of circular RNA CCDC66 (circCCDC66) in gastric cancer, exploring its potential as a biomarker and its influence on tumor progression.

Methods and Materials

To evaluate the clinical and biological significance of circCCDC66, researchers utilized a multi-faceted approach:

  • Clinical Analysis: circCCDC66 expression was measured via quantitative real-time PCR (qRT-PCR) in 70 pairs of gastric cancer tissues and adjacent normal tissues obtained from patients at the First People’s Hospital of Zhenjiang.
  • Cellular Models: Human GC cell lines (SGC-7901, HGC-27, MGC-803, BGC-823) and a normal gastric epithelial cell line (GES-1) were used for in vitro studies.
  • Functional Assays: The impact of circCCDC66 on cell behavior was assessed through knockdown (siRNA) and overexpression (plasmid) experiments. Key metrics included cell proliferation (colony formation), apoptosis (flow cytometry), and metastatic potential (wound healing and transwell invasion assays).
  • In Vivo Validation: A mouse xenograft model was employed to observe the effect of circCCDC66 silencing on actual tumor growth in a living organism.
  • Mechanistic Studies: Western blotting was used to analyze the expression of proteins related to the Epithelial-Mesenchymal Transition (EMT) and key signaling pathways.

Results

Upregulation of circCCDC66 in Gastric Cancer

The study found that circCCDC66 is significantly overexpressed in gastric cancer. Specifically, it was upregulated in 68.5% (48/70) of the clinical GC tissue samples compared to adjacent normal tissues. This elevated expression was not limited to tissues; it was also consistently observed across multiple gastric cancer cell lines compared to the normal GES-1 control line.

Expression of circCCDC66 in gastric cancer tissues and cell lines.

Importantly, higher levels of circCCDC66 were significantly correlated with more advanced tumor stages and the presence of lymphatic metastasis, suggesting that its expression level could serve as a prognostic indicator.

Impact on Tumor Growth and Metastasis

Functional assays revealed that circCCDC66 acts as a potent oncogene. Knocking down circCCDC66 significantly inhibited the proliferation, migration, and invasion of GC cells while simultaneously inducing apoptosis. Conversely, overexpressing circCCDC66 promoted these malignant phenotypes. These findings were further validated in vivo, where tumors derived from circCCDC66-silenced cells were significantly smaller in both volume and weight compared to control groups.

Mechanistic Insights: The c-Myc and TGF-β Axis

The study elucidated that circCCDC66 drives progression by activating two critical oncogenic pathways:

  1. c-Myc Pathway: circCCDC66 promotes the activation of c-Myc, a master regulator of cell growth and metabolism.
  2. TGF-β Signaling and EMT: circCCDC66 triggers the TGF-β pathway, which in turn facilitates the Epithelial-Mesenchymal Transition (EMT). During EMT, cells lose epithelial markers like E-cadherin and gain mesenchymal markers like Vimentin and N-cadherin, significantly increasing their mobility and invasive capacity.

Rescue experiments confirmed these links: when circCCDC66 was overexpressed alongside the inhibition of either c-Myc or TGF-β, the cancer-promoting effects were largely neutralized. This demonstrates that circCCDC66 relies on these pathways to exert its oncogenic influence.

Conclusion

This research identifies circCCDC66 as a key player in gastric cancer pathogenesis. By co-activating the c-Myc and TGF-β signaling pathways, circCCDC66 promotes cell survival, rapid proliferation, and metastatic spread. Given its stability and clinical correlation with disease severity, circCCDC66 represents a promising candidate for a diagnostic biomarker and a potential target for future therapeutic interventions in gastric cancer.

Summary updated

Abstract

<b>Background:</b> CircRNAs play important roles in cancer development and progression and have the potential to serve as cancer biomarkers. The aim of this study was to investigate the role of circular RNA CCDC66 (circCCDC66) in gastric cancer and to reveal the underlying mechanisms. <b>Methods:</b> The expression of circCCDC66 in GC tissues and cell lines was examined by qRT-PCR. The correlation between circCCDC66 expression level and clinicopathological characteristics was analyzed. The biological roles of circCCDC66 in GC cell apoptosis, proliferation, migration and invasion were determined by flow cytometry, cell counting, cell colony formation, wound healing, transwell migration and matrigel invasion assays. The role of circCCDC66 in GC growth was further confirmed by mouse xenograft tumor model. Western blot and qRT-PCR were used to explore the effects of circCCDC66 on epithelial-mesenchymal transition (EMT)-related gene and protein expression. <b>Results:</b> CircCCDC66 expression was elevated in both GC tissues and cell lines compared to adjacent normal tissues and normal gastric epithelial cell line. The upregulation of circCCDC66 in GC tissues was related to tumor stage and lymphatic metastasis. CircCCDC66 knockdown significantly inhibited GC cell proliferation, migration and invasion and induced cell apoptosis in GC cells. On the contrary, circCCDC66 overexpression had the opposite effects. In addition, circCCDC66 knockdown suppressed the tumorigenesis of GC cells in nude mice. Furthermore, circCCDC66 knockdown inhibited the activation of c-Myc and TGF-β signaling pathways and reversed EMT in GC cells. c-Myc and TGF-β interference blocked circCCDC66-mediated promotion of gastric cancer cell proliferation, migration and invasion. <b>Conclusion:</b> CircCCDC66 promotes GC growth and metastasis by activating c-Myc and TGF-β signaling pathways, suggesting that it may serve as a potential biomarker for GC.
BibTeX
@article{xu2020circular,
  author = {Guifang Xu and Yanke Chen and Min Fu and Xueyan Zang and Mingming Cang and Yanlong Niu and Weiya Zhang and Yu Zhang and Zheying Mao and Meng Shao and Hui Qian and Wenrong Xu and Hui Cai and Pengcheng Jiang and Xu Zhang},
  title = {{Circular RNA CCDC66 promotes gastric cancer progression by regulating c-Myc and TGF-β signaling pathways}},
  journal = {Journal of Cancer},
  year = {2020},
  doi = {10.7150/jca.37718},
}
Figure